Journal of Medical Internet Research · 2 Nov 2026
Institutional Approval Is Not Public Authorization: Legitimacy as a Governance Requirement for Clinical AI
Jialin Liuh-index 17, Siru Liuh-index 16
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Clinical AI governance has advanced rapidly in technical validation, regulatory compliance, risk management, human oversight, and postdeployment monitoring. Yet a more fundamental question often remains implicit: under what conditions are health institutions justified in exercising consequential authority through AI over patients, clinicians, and communities? In this Viewpoint, we argue that legitimacy should be recognized as an independent governance requirement, distinct from technical assurance, legal and ethical compliance, trust, acceptance, and institutional approval. Our aim is to distinguish institutional approval from public authorization and to propose a normative framework for authorizing consequential clinical AI deployments. We address health system leaders, clinical AI governance and procurement teams, frontline clinicians, and patient and community representatives. Drawing on theories of legitimacy and public value and published clinical AI governance research, we make the following contributions: (1) the concept of the unclaimed decision, defined as a consequential choice about purpose, threshold, population, or priority for which no actor clearly assumes responsibility for public justification; (2) a tripartite framework comprising procedural authorization, substantive justification, and relational renewal; and (3) practical governance tools to support public justification, contestation, and renewal. These tools include 3 minimum auditable conditions: visibility of deployment; affected-party input before governing conditions are fixed; and conditional reviewability, which requires a predefined trigger that can be invoked by a named actor outside the deploying team. A 5-question public authorization test examines purpose, distribution, exclusion, meaningful choice and contestability, and renewal. Governance intensity should increase with clinical consequence; distributive reach; difficulty of reversal; and the absence of genuine, informed choice. For smaller health care organizations, we propose ways to perform the same core governance functions through existing advisory bodies, targeted interviews, shared regional resources, and standardized documentation. We also outline a heuristic for identifying affected publics, procedures for specifying participation authority and resolving disagreement, and procurement provisions that preserve reviewability across vendor boundaries. These are normative proposals requiring evaluation. Public authorization requires continuing substantive justification; it cannot be inferred from compliance, popularity, or completion of an audit checklist.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Jialin Liu has the highest h-index among the authors (17).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (52)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 32 more references
A free account opens the rest of the citing papers and references on every paper’s page.